Tue. 12 Mar 2024, 4:06pm ET
Benzinga
Earnings, News
Clover Health Investments (NASDAQ:CLOV) reported quarterly sales of $510.30 million which beat the analyst consensus estimate of $480.25 million by 6.26 percent. This is a 43.22 percent decrease over sales of $898.79 million the same period last year.